Tennessee Senate Bill SB2179

Tennessee 2025-2026 Regular Session

• Introduced: 2/2/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 9, Chapter 4, Part 13 and Title 33, Chapter 11, relative to disbursements.

Summary

SB2179 amends Tennessee law governing disbursements for opioid abatement and remediation funding. The bill requires that funds approved for disbursement to a nonprofit organization for statewide, regional, or local opioid abatement purposes be issued as a mix of advance-payment grants and reimbursement grants. The bill states legislative intent that roughly 50% of the grant funds be provided up front as advance payments, and that those advance funds be used for recurring operating costs such as employee wages and salaries. The measure is narrowly focused on how opioid settlement or abatement-related money is paid out, rather than on creating new opioid programs or changing eligibility for funding. It would amend Tennessee Code Annotated, Title 33, Chapter 11, by adding a new requirement for the structure of grants to nonprofits receiving these funds. The act takes effect immediately upon becoming law.

Impact

SB2179 would change state disbursement rules for nonprofit recipients of opioid abatement and remediation funds by requiring a split between advance payments and reimbursements, with an intended 50/50 balance. This affects Tennessee Code Annotated, Section 33-11-105, and would give nonprofits more predictable upfront cash flow for recurring expenses while still preserving reimbursement oversight for part of the funding. The bill could influence how opioid settlement dollars are administered across statewide, regional, and local programs and may affect nonprofit budgeting, payroll, and grant compliance practices.

Sentiment

The available voting history suggests the bill received mixed but favorable consideration in committee. The Senate Health and Welfare Committee recommended passage with amendments by a 5-4 vote, indicating support was present but not broad or unanimous. No transcript excerpts are available, so the discussion record does not show detailed arguments, but the close vote suggests the bill was somewhat controversial or at least raised concerns among several committee members.

Contention

The main point of contention appears to be the required funding structure for nonprofit opioid abatement grants, especially the mandate that approximately half of the funds be advanced rather than reimbursed. Supporters likely view this as a way to help nonprofits cover recurring costs and maintain operations, while opponents may be concerned about reduced fiscal control, accountability, or the appropriateness of using settlement funds for ongoing administrative expenses such as salaries. The 5-4 committee vote indicates disagreement over whether this payment approach is the best use of opioid abatement dollars.